Korean J Med.  2011 Jun;80(Suppl 2):S245-S248.

Successful Treatment of Vancomycin-Resistant Enterococci Peritonitis with Quinupristin/Dalfopristin in a Patient on Continuous Ambulatory Peritoneal Dialysis

Affiliations
  • 1Department of Internal Medicine, Bong Seng Memorial Hospital, Busan, Korea. kidney119@hotmail.com

Abstract

Peritonitis is one of the major complications of continuous ambulatory peritoneal dialysis (CAPD). Multidrug-resistant organisms, including vancomycin-resistant enterococci (VRE), have been reported as pathogens of CAPD-associated peritonitis. The incidence of hospital-associated infections caused by VRE has recently increased. Some drugs, such as linezolid and quinupristin/dalfopristin, have been introduced as treatments of VRE infection. However, there is limited information about the effects of VRE-associated CAPD peritonitis. We present a case of successful treatment of CAPD peritonitis caused by VRE with quinupristin/dalfopristin and include a review of the literature.

Keyword

Vancomycin-resistant enterococcus infection; Peritoneal dialysis, Continuous ambulatory; Peritonitis; Quinupristin/dalfopristintin

MeSH Terms

Acetamides
Humans
Incidence
Oxazolidinones
Peritoneal Dialysis, Continuous Ambulatory
Peritonitis
linezolid
Acetamides
Oxazolidinones
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error